GAM Holding AG lowered its stake in ICU Medical, Incorporated (NASDAQ:ICUI) by 0.5% during the first quarter, according to the company in its most recent filing with the SEC. The fund owned 90,000 shares of the medical instruments supplier’s stock after selling 452 shares during the period. ICU Medical makes up 0.9% of GAM Holding AG’s portfolio, making the stock its 10th largest holding. GAM Holding AG owned 0.44% of ICU Medical worth $21,540,000 as of its most recent filing with the SEC.
A number of other institutional investors and hedge funds also recently made changes to their positions in ICUI. TIAA CREF Investment Management LLC grew its position in ICU Medical by 230.8% during the third quarter. TIAA CREF Investment Management LLC now owns 165,570 shares of the medical instruments supplier’s stock valued at $46,815,000 after acquiring an additional 115,526 shares during the period. Vanguard Group Inc lifted its stake in shares of ICU Medical by 12.0% during the third quarter. Vanguard Group Inc now owns 1,483,501 shares of the medical instruments supplier’s stock worth $419,459,000 after purchasing an additional 158,798 shares in the last quarter. We Are One Seven LLC acquired a new position in shares of ICU Medical during the fourth quarter worth about $32,000. Huntington National Bank lifted its stake in shares of ICU Medical by 26.6% during the fourth quarter. Huntington National Bank now owns 443 shares of the medical instruments supplier’s stock worth $102,000 after purchasing an additional 93 shares in the last quarter. Finally, New York State Teachers Retirement System lifted its stake in shares of ICU Medical by 0.4% during the fourth quarter. New York State Teachers Retirement System now owns 24,739 shares of the medical instruments supplier’s stock worth $5,681,000 after purchasing an additional 100 shares in the last quarter. Institutional investors and hedge funds own 90.05% of the company’s stock.
Shares of NASDAQ:ICUI traded down $3.72 during trading on Wednesday, hitting $245.53. 148,600 shares of the company traded hands, compared to its average volume of 183,230. The company has a market capitalization of $5.08 billion, a PE ratio of 31.85 and a beta of 0.72. The stock has a fifty day simple moving average of $231.21. ICU Medical, Incorporated has a one year low of $210.94 and a one year high of $321.70.
ICU Medical (NASDAQ:ICUI) last posted its earnings results on Thursday, May 9th. The medical instruments supplier reported $2.35 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.96 by $0.39. The company had revenue of $330.93 million during the quarter, compared to analyst estimates of $318.97 million. ICU Medical had a return on equity of 13.70% and a net margin of 4.04%. The business’s revenue was down 11.0% compared to the same quarter last year. During the same period in the prior year, the company earned $2.26 earnings per share. Equities research analysts forecast that ICU Medical, Incorporated will post 8.55 EPS for the current year.
A number of brokerages have commented on ICUI. Zacks Investment Research cut ICU Medical from a “hold” rating to a “sell” rating in a research note on Wednesday, June 12th. BidaskClub upgraded ICU Medical from a “sell” rating to a “hold” rating in a research note on Friday, May 24th. TheStreet upgraded ICU Medical from a “c+” rating to a “b” rating in a research note on Friday, May 10th. Finally, Raymond James cut their price objective on ICU Medical from $315.00 to $300.00 and set a “strong-buy” rating on the stock in a research note on Friday, March 1st. One analyst has rated the stock with a sell rating, two have assigned a hold rating and one has given a strong buy rating to the stock. ICU Medical currently has an average rating of “Hold” and a consensus price target of $281.00.
In related news, CFO Scott E. Lamb sold 25,000 shares of the stock in a transaction that occurred on Wednesday, June 26th. The stock was sold at an average price of $250.00, for a total value of $6,250,000.00. Following the completion of the transaction, the chief financial officer now directly owns 34,984 shares of the company’s stock, valued at approximately $8,746,000. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Robert S. Swinney sold 229 shares of the stock in a transaction that occurred on Friday, April 12th. The stock was sold at an average price of $231.43, for a total value of $52,997.47. Following the completion of the transaction, the director now directly owns 18,076 shares of the company’s stock, valued at $4,183,328.68. The disclosure for this sale can be found here. Insiders have sold 37,921 shares of company stock valued at $9,221,607 over the last ninety days. Corporate insiders own 11.40% of the company’s stock.
ICU Medical Profile
ICU Medical, Inc develops, manufactures, and sells medical devices used in vascular therapy, critical care, and oncology applications worldwide. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patient's vein.
Read More: The risks of owning bonds
Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.